KF-1604

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameKF-1604

Drug Alias NameKF-1604

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 4 inhibitors

TargetsFibroblast growth factor receptor 4

Therapy Area/IndicationsLiver NeoplasmsBiliary Tract Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunoForge Inc

China Registration ClassN/A

Active CompaniesImmunoForge Inc

Inactive CompaniesN/A

Active IndicationsLiver NeoplasmsBiliary Tract Neoplasms

Inactive IndicationsN/A

ATC CodeN/A